Your browser doesn't support javascript.
loading
Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton's Jelly.
Sypecka, Monika; Bzinkowska, Aleksandra; Sulejczak, Dorota; Dabrowski, Filip; Sarnowska, Anna.
Affiliation
  • Sypecka M; Mossakowski Medical Research Institute, Translational Platform for Regenerative Medicine, Polish Academy of Sciences, 02-106 Warsaw, Poland.
  • Bzinkowska A; Mossakowski Medical Research Institute, Translational Platform for Regenerative Medicine, Polish Academy of Sciences, 02-106 Warsaw, Poland.
  • Sulejczak D; Department of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.
  • Dabrowski F; Department of Obstetrics, Perinatology and Neonatology, Center for Medical Postgraduate Education, 01-813 Warsaw, Poland.
  • Sarnowska A; Mossakowski Medical Research Institute, Translational Platform for Regenerative Medicine, Polish Academy of Sciences, 02-106 Warsaw, Poland.
Int J Mol Sci ; 24(1)2022 Dec 30.
Article in En | MEDLINE | ID: mdl-36614096
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wharton Jelly / Mesenchymal Stem Cells Type of study: Guideline Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: Poland Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wharton Jelly / Mesenchymal Stem Cells Type of study: Guideline Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: Poland Country of publication: Switzerland